Last updated on August 2018

Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto Respimat (AERIAL )


Brief description of study

The objective of this NIS is to measure changes in health status including functional status using CCQ scores in COPD patients receiving treatment with Spiolto Respimat according to label after approximately 6 weeks in routine clinical practice.

Detailed Study Description

The objective of this NIS is to measure changes in health status including functional status using CCQ scores in COPD patients receiving treatment with Spiolto Respimat according to label after approximately 6 weeks in routine clinical practice.

In visit 1, patient data on demographics, smoking status, medical history, breathlessness, general condition, health and functional status and adverse drug reactions will be collected. In visit 2, after approximately 6 weeks, data on smoking status, concomitant diseases and medication, general condition, health and functional status and adverse drug reactions will be collected; additionally data on patient satisfaction, continuation or discontinuation of treatment and the reason in case of discontinuation.

Clinical Study Identifier: NCT03165045

Contact Investigators or Research Sites near you

Start Over

Boehringer Ingelheim

Dres. Jung/Jung
Deggingen, Germany
5.14miles
  Connect »

Boehringer Ingelheim

Dr. Jung
Bad Ditzenbach, Germany
6.39miles
  Connect »